Leukodepletion of blood products: A measure to improve quality and safety;Leukodepletie van bloedproducten: Een maatregel ten behoeve van kwaliteit en veiligheid

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 22, 2000, Pages 1033-1036

  Van Aken, W G ^a,b   Brand, A ^a   Van Der Poel, C L ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD FILTRATION; BLOOD TRANSFUSION; GOOD MANUFACTURING PRACTICE; HLA SYSTEM; NETHERLANDS; POSTOPERATIVE INFECTION; QUALITY CONTROL; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; VIRUS TRANSMISSION;

BLOOD BANKS; BLOOD COMPONENT REMOVAL; BLOOD TRANSFUSION; CONSUMER PRODUCT SAFETY; COST-BENEFIT ANALYSIS; GREAT BRITAIN; HUMANS; LEUKOCYTES; LIABILITY, LEGAL; NETHERLANDS;

EID: 0034720610     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Gezondheidsraad. Commissie Variant Creutzfeldt-Jakob ziekte en leukodepletie. Leukodepletie van bloedprodukten. Publicatienr 2000/04. Den Haag: Gezondheidsraad; 2000.
2. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 4th ed. Straatsburg: Council of Europe Publishing; 1998.
3. Heddle NM. The efficacy of leukodepletion to improve platelet transfusion response: a critical appraisal of clinical studies. Transfus Med Rev 1994;8:15-28.
4. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997;337:1861-9.
5. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14-7.
6. Sirchia G, Rebulla P, Parravicini A, Carnelli V, Gianotti GA, Bertolini F. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter. Transfusion 1987;27:402-5.
7. Pamphilon DH, Rider JR, Barbara JA, Williamson LM. Prevention of transfusion-transmitted cytomegalovirus infection. Transfus Med 1999;9:115-23.
8. Brand A, Houbiers JGA. Clinical studies of blood transfusion and cancer. In: Vamvakas EC, Blajchman MA, editors. Immunomodulatory effects of blood transfusion. Bethesda, Md.: AABB Press; 1999. p. 145-90.
9. Houbiers JGA, Brand A, Watering LMG van de, Hermans J, Verwey PJ, Bijnen AB, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573-8.
10. Brand A. The risk of mortality in major surgery: influence of blood transfusion? In: Barbara JAJ, Leikola J, Rossi U, editors. Proceedings of ESTM residential course: Risk perception and risk assessment in transfusion medicine. Brussel: European School of Transfusion Medicine; 2000. p. 133-7.
11. Adverse ocular reactions following transfusions - United States, 1997-1998. MMWR Morb Mortal Wkly Rep 1998;47:49-50.
12. Cool WA van, Meijerink PHS. De ziekte van Creutzfeldt-Jakob; een jaar later. Ned Tijdschr Geneeskd 1997;141:613-5.
13. Brown P, Cervenakova L, McShane LM, Barber P, Rubinstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999;39:1169-78.
14. Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998;38:810-6.
15. Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann H, et al. A crucial role for B cells in neuroinvasive scrapie. Nature 1997;390:687-90.
16. Hill AF, Desbruslais M, Joiner S, Sidle KC. Gowland I, Collinge J, et al. The same prion strain causes vCJD and BSE [letter]. Nature 1997;389:448-50, 526.
17. Hill AF, Zeidler MZ, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349: 99-100.